The aim of this study was to evaluate the fibrinolytic system by measurement of fibrinogen, plasminogen, tissue-type plasminogen activator (t-PA), and plasminogen activator inhibitor-1 (PAI-1) in healthy normotensive subjects and in patients with essential hypertension. A group of 21 healthy normotensive subjects [age, 39.2 6 1.8 years; 8 males, 13 females; body mass index (BMI) = 27.9 kg/m 2 ] and 42 patients with untreated essential hypertension (age, 47.6 6 1.7 years; 19 males, 23 females; BMI = 28.3 kg/m 2 ) were studied. Blood samples and clinical measurement were taken between 7 AM and 9 AM by an observer in a blind fashion. The systolic/diastolic blood pressure of normotensive subjects was 121.3 6 2.5/78.4 6 1.3 mm Hg and that of hypertensive patients was 166.4 6 4.3/102.9 6 1.83 mm Hg, measured in the sitting position. Plasma fibrinogen levels in the normotensive and hypertensive individuals were 295.7 6 9.4 mg/dL and 305.67 6 10.9 mg/dL, respectively (P = 0.456). The corresponding values for plasminogen were 71.4 6 3.8% and 89.5 6 2.5%, (P = 0.0031), for t-PA were 6.3 6 0.5 ng/mL and 7.6 6 0.4 ng/mL (P = 0.0487), and for PAI-1 were 46.9 6 5.1 ng/mL and 63.0 6 5.6 ng/mL (P = 0.0324), respectively. In conclusion, patients with essential hypertension have disequilibrium in the fibrinolytic system with a tendency toward a hypercoagulability state when compared with normotensive subjects. This state could explain, in part, the thrombotic complications that occur with a higher frequency in hypertensive patients as compared with normotensive subjects.
INTRODUCTION
Hypertension complications and mortality are the result of, in large part, ischemia and disturbances in blood flow in target organs because of atherothrombosis in large and small arteries. Alteration in the fibrinolytic system has been reported in hypertensive patients. 1, 2 Fibrinolysis is controlled by the plasminogen activator system. The proteolytic activity of this system is mediated by plasmin, which is generated from plasminogen by one of the 2 plasminogen activators. 3 Plasminogen activator inhibitor-1 (PAI-1) inhibits the proteolytic activity. 4 Several studies have shown that essential hypertension is associated with abnormalities in hemostatic/fibrinolytic balance caused by increased plasma levels of fibrinogen and PAI-1 and decreased tissue plasminogen activator (t-PA). 5, 6 Evidence is accumulating that indicates that the imbalance predicts future vascular events both in ischemic heart disease and stroke. 7 Thus, individuals who present with impaired fibrinolytic activity tend to have increased risk for ischemic cardiovascular events and reduced fibrinolysis partly as a result of reduced nitric oxide availability. 8 Increased levels of fibrinogen have been identified as a major independent risk factor for cardiovascular disease. 9, 10 Increased levels of fibrinogen are also associated with higher traditional cardiovascular risk factors 11 suggesting that elevation of fibrinogen may be the pathway by which these risk factors exert their effect. Fibrinogen may increase cardiovascular risk factors by several mechanisms, including 1) binding specifically to activated platelet through glycoprotein IIb/IIIa, which promotes platelet aggregation; 2) promoting formation of increased levels of fibrin; and 3) contributing to plasma viscosity. Fibrinogen is also an acute-phase reactant that is increased in inflammatory states. 12 Hypertension is the most important risk factor for myocardial infarction and stroke, 13 accelerating development of atherosclerosis and increasing shear stress leading to plaque rupture and thrombosis. Hypertension also clusters with other risk factors such as hypercholesterolemia, hypertriglyceridemia, obesity, and insulin resistance 14 ; with complications predominantly occurring as a result of thrombotic rather than hemorrhagic, 15 hypertension may exert its effect in part through promotion of a prothrombotic state. Hemostatic factors such as fibrinogen, factor VII, and elevated levels of PAI-1 and t-PA has been associated with increased risk for cardiovascular disease. 16, 17 The aim of the present study was to assess the status of the fibrinolytic system in hypertension by measurement of fibrinogen, plasminogen, t-PA, and PAI-1 in a group of patients with untreated essential arterial hypertension and compare the values obtained in a group of healthy normotensive subjects.
PATIENTS AND METHODS
This study was carried out in 2 groups of subjects who were evaluated at the hypertension clinic; written informed consent was obtained from each subject previous to the start of evaluations.
One group compromised 21 healthy normotensive subjects, 8 male and 13 female, age 29.24 6 1.81 years and body mass index 27.9 kg/m 2 .
The second group included 42 patients with untreated essential hypertension: 19 males 23 females, age 47.62 6 1.72 years and body mass index 28.3 kKg/m 2 .
Hypertension was diagnosed when the systolic blood pressure (BP) was $140 mm Hg and/or the diastolic BP was $90 mm Hg on at least 3 separate occasions; BP was measured in supine and sitting positions in a quiet room using a mercury sphygmomanometer after the patient had rested for at least 15 minutes. Phase I and V of Korotkoff sounds estimated systolic and diastolic BP, respectively. All measurements were made by the same trained observer. No patients were receiving antihypertensive therapy either because of a new diagnosis or omitted treatment for at least 6 weeks previous to evaluations. A detailed history was obtained, including physical examination and electrocardiogram conducted on each subject.
Patients with a history of acute coronary artery disease in the previous 4 months, secondary hypertension, renal failure, liver disease, or other serious illness were excluded from the study. Subjects' weight and stature was obtained by the usual procedure with light clothing and without shoes; body mass index (BMI) was calculated as weight/height (kg/m 2 ). Characteristics of patients are summarized in Table 1 . All subjects had fasted for at least 12 hours and blood samples were taken between 7 and 9 AM by an observer in a blinded fashion. Fibrinogen (886 10 clotting assay; Sigma Diagnostic, St. Louis, MO), plasminogen (Accucolor Plasminogen; Sigma Diagnostic), t-PA antigen [enzyme-linked immunosorbent assay (ELISA); Innogenetics, Zwÿ naarde Belgium], and PAI-1 antigen (ELISA assay; Hyphen BioMed, Andrésy, France) were carried out in each subject using citrated plasma (9:1 proportion, 0.129 M).
RESULTS
Twenty-one normotensive subjects and 42 hypertensive patients who entered into the study showed systolic BP, diastolic BP, and mean arterial pressure of 121.3 6 2.5 mm Hg; 78.4 6 1.3 mm Hg, and 92.7 6 1.6 mm Hg, respectively, in the normotensive group and 166.4 6 4.3 mm Hg, 102.9 6 1.83 mm Hg, and 124.1 6 2.5 mm Hg, respectively, in the hypertensive group with statistical significantly for the 3 values (P # 0.001).
Fibrinogen was 295.7 mg/dL 6 9.4 in the normotensive group and 305.67 6 10.9 mg/dL in the hypertensive group (not significant); plasminogen was 71.44 6 3.8% and 89.5 6 2.5% in normotensive and hypertensive patients, respectively (P # 0.0031); t-PA was 6.3 6 0.50 ng/mL in the normotensive group and 7.61 6 0.40 ng/mL in the hypertensive patients (P # 0.0487) and the PAI-1 was 46.88 6 5.1 ng/mL and 63.03 6 5.6 ng/mL (P # 0.0324) in both groups, respectively (table 2) . Correlation with mean arterial pressure was found for plasminogen and t-PA but not for PAI-1 (Figures 1-3 ). Correlation between t-PA and PAI-1 showed a good positive correlation (P # 0.0001) ( Fig. 4 ).
DISCUSSION
The fibrinolytic system represents a crucial defense mechanism against intravascular thrombosis. One determinant of the fibrinolytic capacity of circulating blood is the dynamic balance between plasminogen activators and inhibitors. The fibrinolytic process is mainly influenced by the interaction between t-PA, which promotes fibrinolysis, and its specific inhibitor, PAI-1. The ratio of active t-PA to active PAI-1 has been reported to be approximately 1:8 in healthy male subjects compared with 1:50 in men with thrombotic disease. 18 In the present study, it was found in 63 subjects that increasing BP was associated with impaired fibrinolytic state, so plasminogen and t-PA levels Fibrinolytic System in Normotension and Hypertension increased as a function of rising mean arterial pressure (MAP). However, PAI-1 plasma levels were not correlated to MAP. Impaired fibrinolysis has been mainly evaluated with the use of PAI-1 and also high concentrations of t-PA. 19 Furthermore, increased plasma levels of both t-PA and PAI-1 are associated with an increased risk of myocardial infarction and stroke. 20 Therefore, these findings of increasing PAI-1 and t-PA levels in relation to increasing BP are compatible with a decreased fibrinolytic state in hypertensive patients.
Prior studies evaluated the association of hemostatic factors and hypertension but are limited by smaller sample size 21 or lack of adjustment for one or more of the following variables: diabetes, triglycerides, alcohol intake, or use of antihypertensive therapy. 22 Wall et al 23 studied 39 young male subjects with untreated borderline hypertension and 17 normotensive control subjects matched for BMI, smoking, alcohol consumption, and total cholesterol, low-density lipoproteins, high-density lipoproteins, and triglyceride levels. The 24-hour ambulatory BP recordings were performed and an average value was computed for each subjects. Borderline hypertensive subjects had a higher concentration of t-PA levels than did control subjects, whereas there were no significant differences in t-PA activity or PAI-1 levels between groups. The results of this study support the presence of decreased fibrinolytic potential in a very selective group of young men with borderline hypertension who are unlikely to have significant undiagnosed arteriosclerosis; in the present study, it was found levels of t-PA and PAI-1 higher in the hypertensive groups and both values were statistically significant. The ratio PAI-1/t-PA tends to be higher in hypertensive groups, but did not reach significance, perhaps related with sample size.
The risk of sustaining thromboembolic complications such as ischemic stroke and myocardial infarction is significantly increased in patients with long-term arterial hypertension. 24, 25 The exact mechanism by which elevations in arterial BP may promote such end points remains unclear, but the fibrinolytic system may play an important role as has been recognized in the pathogenesis of atherothrombotic events. 26 In contrast with the present small case-control study, the results of the large Framingham Offspring Study (n = 2652; 1193 men and 1459 women) indicate that plasma levels of PAI-1 and t-PA increase as a function of rising systolic and diastolic BP in both men and women. 27 This association persisted even after adjustment for age, BMI, smoking, diabetes, alcohol intake, triglycerides, highdensity lipoprotein cholesterol, and total cholesterol, but there was no association between BP and fibrinogen as the present study suggests. Another large cohort study, the Monitoring of Trend and Determinant in Cardiovascular Disease (MONICA) study, Eliasson, et al 28 performed a cross-sectional analysis of data from 1558 participants and reported that in men but not in women, diastolic BP predicted low t-PA activity and high PAI-1 activity. Furthermore, PAI-1 activity increased with triglycerides in both sexes. A high PAI-1 activity was also correlated with systolic BP both in men and women. Endogenous t-PA has been hypothesized to be a marker of baseline fibrinolytic capacity and may be a marker for significant atherosclerosis in symptom-free individuals. 29 The positive association of the risk of coronary events with the concentration of plasma levels of t-PA and von Willebrand factor antigen levels, both of which are released by endothelial cells, points to possible endothelial perturbation in patients prone to coronary atherothrombosis such as hypertensive patients. 30 Fibrinogen has been related as an independent risk factor for cardiovascular disease. 9, 10 In the Framingham Offspring Study, 27 fibrinogen was found to be an independent risk factor for hypertension. However, in the present study, there was no significant difference in fibrinogen levels in normotensives and hypertensive individuals, and there was no association between fibrinogen levels and MAP.
Hypertension has been reported to be closely related to obesity, hyperlipidemia, and glucose intolerance, and all elements of the insulin resistance syndrome. 31 However, in the study, all these parameters were not different in normotensives and hypertensives.
In conclusion, hypertensive patients when compared with normotensive subjects tended to show a disbalanced fibrinolytic system and tendency to a hypercoagulability state. Results could explain the more frequent thrombotic complications seen in the hypertensive patients suggesting that impaired fibrinolysis plays a role in the pathogenesis of cardiovascular diseases and complications of hypertension. Modifications of this hypercoagulable state may have a beneficial effect on the increased risk in subjects with hypertension.
